Author | Leora Horn, MD, MSc

Articles

NSCLC With EGFR Exon 20 Shows Benefit With Mobocertinib Over Chemotherapy

August 11, 2020

Leora Horn, MD, MSc, discusses the data accrued from Flatiron and from a phase 1/2 trial of patients with refractory non–small cell lung cancer with EGFR exon 20 insertions receiving mobocertinib compared with currently approved therapies.

Real-World Comparison Assesses Mobocertinib in NSCLC With EGFR Exon 20

July 29, 2020

Leora Horn, MD, MSc, discusses the real-world data outcomes compared with clinical trial data of mobocertinib from a retrospective study in patients with refractory non–small cell lung cancer with EGFR exon 20 insertions.